Michael Wernecke
Impact in
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
- Health 12
- Vaccine Coverage and Hesitancy 9
-
- COVID-19 epidemiological studies 4
- Co-authors
- Jeffrey A. KelmanThomas MaCurdyDavid J. GrahamChris WorrallYoganand ChillarigeMarsha E. ReichmanKatrina MottMargie R. Goulding
- Journals
- The Journal of Infectious Diseases (8 papers)Pharmacoepidemiology and Drug Safety (7 papers)Vaccine (6 papers)JAMA Internal Medicine (5 papers)Clinical Infectious Diseases (4 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Michael Wernecke
54 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Internal Medicine 399
- Cardiology and Cardiovascular Medicine 798
- Epidemiology 724
- Health 170
- Hematology 160
Countries citing papers authored by Michael Wernecke
This map shows the geographic impact of Michael Wernecke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wernecke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wernecke more than expected).
Fields of papers citing papers by Michael Wernecke
This network shows the impact of papers produced by Michael Wernecke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wernecke. The network helps show where Michael Wernecke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Wernecke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 10 | |
| 7 | 2021 | 74 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 1 | |
| 11 | 2020 | 4 | |
| 12 | 2020 | 1 | |
| 13 | 2019 | 98 | |
| 14 | 2019 | 15 | |
| 15 | 2019 | 16 | |
| 16 | 2018 | 6 | |
| 17 | 2017 | 20 | |
| 18 | 2017 | 86 | |
| 19 | 2016 | 67 | |
| 20 | Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation Hit paper breakdown → | 2014 | 498 |
About Michael Wernecke
Michael Wernecke is a scholar working on Health, Modeling and Simulation, Infectious Diseases, Epidemiology and Toxicology, having authored 57 papers that have together received 2.0k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (15 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Vaccine Coverage and Hesitancy (9 papers), Respiratory viral infections research (6 papers), Peripheral Neuropathies and Disorders (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), COVID-19 epidemiological studies (4 papers) and Herpesvirus Infections and Treatments (4 papers). The work is most often cited by research in Internal Medicine (399 citations), Cardiology and Cardiovascular Medicine (798 citations), Epidemiology (724 citations), Health (170 citations) and Hematology (160 citations). Michael Wernecke has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Jeffrey A. Kelman, Thomas MaCurdy, David J. Graham, Chris Worrall, Yoganand Chillarige, Marsha E. Reichman, Katrina Mott, Margie R. Goulding, Mary Southworth and Richard A. Forshee. Their work appears in journals such as The Journal of Infectious Diseases, Pharmacoepidemiology and Drug Safety, Vaccine, JAMA Internal Medicine and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.